# Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder

> **NCT03899194** · NA · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 350 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** fish oil capsules
- **DRUG:** escitalopram

## Key facts

- **NCT ID:** NCT03899194
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899194, "Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03899194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*